SCHEMBL9751128

SCHEMBL9751128

CCCC=CN=[C:1]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19557815 0.77
SCHEMBL5691862 0.75 TSHR (0.35)
SCHEMBL2359587 0.75 TSHR (0.35)
SCHEMBL1680583 0.73
SCHEMBL1680582 0.73
SCHEMBL24141565 0.72
SCHEMBL13328647 0.71
SCHEMBL28148278 0.71
SCHEMBL37295 0.69
SCHEMBL37294 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0321556-A4 USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM 1991-06-12 EP claimed
EP-0321556-A1 USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM Memorial Hospital for Cancer and Allied Diseases (US) 1989-06-28 EP claimed
WO-1988010114-A1 USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) 1988-12-29 WO claimed